Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cardiome Pharma Corp (NASDAQ:CRME)

3.05
Delayed Data
As of Aug 24
 -0.03 / -0.97%
Today’s Change
2.95
Today|||52-Week Range
10.40
-62.39%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues789.0K4.5M30.0M20.9M
 
 
 
 
 
Cost of Goods Sold--936.0K10.0M6.6M
 
 
 
 
Depreciation And Amortization1.2M649.0K2.2M2.2M
 
 
 
 
 
 
Operating ExpensesGross Income--2.9M17.9M12.1M
 
 
 
 
General Expenses15.6M16.9M34.5M34.2M
 
 
 
 
 
Research And Development6.0M476.0K637.0K3.2M
 
 
 
 
 
Total Operating Expenses16.9M18.5M46.6M43.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.1M-14.0M-16.6M-22.1M
 
 
 
 
 
Extraordinary Credit11.2M20.8M0.000.00
 
 
 
Extraordinary Charge-10.0M-2.7M0.000.00
 
 
 
Interest Expense On Debt4.3M87.0K1.5M2.3M
 
 
 
 
 
Other Expenses843.0K825.0K-110.0K-132.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.3M4.9M-18.2M-24.5M
 
 
 
 
 
Income Taxes0.00-102.0K-49.0K-11.0K
 
 
 
 
Net Income-18.3M4.8M-18.2M-24.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.3M12.8M16.2M18.2M
 
 
 
 
 
Shares To Calculate EPS Diluted12.3M12.9M16.2M18.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.50$0.37-$1.12-$1.34
 
 
 
 
 
EPS Diluted-$1.50$0.37-$1.12-$1.34